|
Towards Establishing a Center for High Throughput Structure-Based Drug Discovery (SBU-DD) (PI: Markus Seeliger), in collaboration with Brookhaven National Lab
|
Co-I |
07/01/2023-
12/31/2024 |
Biomedical Science Innovation Seed Grant, OVPR- Stony Brook U
|
|
Interactions between a novel cancer target and inhibitors (PI: Ivet Bahar in collaboration with Shardule Shah at Lime Therapeutics)
|
PI |
07/01/2023-
07/15/2024 |
ARAD Program of Center
for Biotech (NYSTAR) & Lime Therapeutics
|
| The mechanism of allosteric modulation of glutamate transporters (PI: A Mortensen and Olga Boudker) |
Co-I |
2020-2024 |
NINDS R01 |
| Identification of genetic factors and novel compounds for alleviating jet lag (PI: Stephen Chang, UPMC) |
Co-I |
2021-2024 |
Greater Houston Comm |
| Immunosuppression in Acute Lung Injury
(PI: Mallampalli, Ohio State U) |
co-investigator |
2019-2024 |
NIH-NHLBI P01 HL114453 |
| New Therapies for Liver Fibrosis and Hyperproliferation in a1-AT Deficiency (PI: Perlmutter, Wash U) |
PI of Comp Pharmacology Core |
2012-2024 |
NIH-NIDDK P01 DK96990 |
| Integrated, Interdisciplinary, Comprehensive Inter-University Ph.D. Program in Comp Biol. PIs: Faeder* and Bahar (Pitt), and Bar-Joseph and Russell (CMU) |
MPI (Faeder* and Bahar (Pitt); Bar-Joseph and Russell (CMU)) |
2009-2024 |
NIH-NIBIB T32 EB009403 |
Computer-aided discovery and development of drugs against rare diseases |
PI |
2021-2023 |
Congruence, Inc. |
| Biological Springs as Allosteric Modulators (MPI: Itzhaki (Cambridge, UK), Gordon (Victoria U, Canada), Yang (Tsinghua U, Taiwan), and Bahar (Pitt) |
MPI |
2020-2023 |
HFSP |
| BTRC on High Performance Computing for Multiscale Modeling of Biological Systems (MMBioS) (PI: Bahar) |
PI (2012-2021)
TDP Leader (2021-2023) |
2012-2023 |
NIH-NIGMS P41 GM103712 |
Controlling Monolysocardiolipin/cytochrome c Peroxidase Complexes in Barth Syndrome (PI's: Greenberg (Wayne State) and Kagan (Pitt)) |
co-investigator |
2020-2022 |
NIH-NIGMS R01 |
| Allosteric modulation of dopamine transport-Functional and Biochemical Studies (PI: Ole Mortensen, Drexel University) |
co-investigator |
2020-2022 |
NIH R01 |
| Identification of drug candidates for PTHR (PIs: Bahar and Vilardaga, Pitt) |
MPI (Bahar* and Vilardaga) |
2019-2020 |
NIH-CTSI Pilot UL1TR001857 |
| NIDA Center of Excellence for Computational Drug Abuse Research (CDAR) (PIs: Xie* (Pitt), Bahar (Pitt) and Xing- Carnegie Mellon University) |
MPI (Xie,* Bahar, and Xing) |
2014-2020 |
NIH - NIDA
P30 DA035778 |
| Center for Medical Countermeasures against Radiation (CMCR) Signature-Directed, Sequential Delivery of Radiation Mitigators (PI: Greenberger, UPMC) |
PI of Comp System Pharmacology Core |
2010-2020 |
NIH-NIAID
U19 AI068021 |
| BD2K (Big Data to Knowledge) Center for Causal Discovery (CCD) (PIs: Cooper* and Bahar, Pitt) |
MPI (Cooper* and Bahar) |
2014-2019 |
NIH-NHGRI U54 HG008540 |
